arXiv:2608. 13518v1 Announce Type: new Abstract: Many clinical prediction models treat post-intervention outcomes as a one-step mapping from baseline measurements to a future endpoint.
By Yunsung Chung, Yingshuo Liu, Abboud F. Hassan, Han Feng, Mary M. Maleckar, Nassir Marrouche, Jihun Hamm
Many clinical prediction models treat post-intervention outcomes as a one-step mapping from baseline measurements to a future endpoint. However, recovery after a procedure often unfolds as an irregular trajectory: clinical observations, medication changes, repeat interventions, and physiological measurements are recorded asynchronously and can change risk assessment over time.
The paper introduces Observation‑Anchored Selective Assimilation (OASA) for forecasting tumor‑state proxies in post‑treatment glioma patients using serial MRI observations. OASA anchors the patient‑specific state with an intermediate observation and selectively updates it via a tiered rule and voxel‑wise soft gate, outperforming baseline methods in Dice score at certain thresholds. The approach is validated on 120 patient triplets and the code is publicly released.
By Yeonjae Jung, Minwoo Shin
arXiv:2512.08029v4 Announce Type: replace
Abstract: Clinical decision-making in oncology requires forecasting how disease evolves under treatment, yet most AI systems remain static predictors that ca...
By Tianxingjian Ding, Yuanhao Zou, Chen Chen, Mubarak Shah, Yu Tian
FRESH (Fusion of Recent Evidence and Subject Histories) is a method that integrates population‑level summary results—such as published clinical trials, registry summaries, prior natural‑history studies, and peer‑reviewed indirect comparisons—into predictive models trained on patient‑level data. It recalibrates a generative model trained on patient data so that its predictions match specified aggregate statistics for a target population, achieving this with minimal perturbation in an information‑geometric sense. The recalibrated model can be used directly or to update the original generative model, enabling applications like contextualizing single‑arm trials, simulating clinical‑trial designs, and conducting comparative‑effectiveness analyses of on‑market therapies.
By Franklin Fuller, Daniele Bertolini, Samantha Liang, Jason Christopher, Aaron M. Smith
arXiv:2610.26923v1 Announce Type: cross
Abstract: Treatment planning is intrinsically counterfactual: clinicians must compare how a patient's tumor and survival would evolve under competing regimens,...
By Huanlong Gao, Xuelei He, Fengjun Zhao, Xiaowei He